Oxford Cannabinoid Technologies Stock Price To Sales
| OCTHF Stock | USD 0 0.00 0.00% |
Oxford Cannabinoid Technologies fundamentals help investors to digest information that contributes to Oxford Cannabinoid's financial success or failures. It also enables traders to predict the movement of Oxford Pink Sheet. The fundamental analysis module provides a way to measure Oxford Cannabinoid's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Cannabinoid pink sheet.
Oxford |
Oxford Cannabinoid Technologies Company Price To Sales Analysis
Oxford Cannabinoid's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Oxford Cannabinoid Technologies has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
Oxford Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Cannabinoid's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford Cannabinoid could also be used in its relative valuation, which is a method of valuing Oxford Cannabinoid by comparing valuation metrics of similar companies.Oxford Cannabinoid is currently under evaluation in price to sales category among its peers.
Oxford Fundamentals
| Current Valuation | (3.87 M) | |||
| Shares Outstanding | 960.42 M | |||
| Shares Owned By Insiders | 44.08 % | |||
| Shares Owned By Institutions | 2.72 % | |||
| Price To Book | 0.41 X | |||
| Gross Profit | (3.15 M) | |||
| EBITDA | (5.63 M) | |||
| Book Value Per Share | 0.01 X | |||
| Market Capitalization | 11.9 M |
About Oxford Cannabinoid Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Cannabinoid Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Cannabinoid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Cannabinoid Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Cannabinoid financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Cannabinoid security.